menu
    • menu

    Company profile for Atara Biotherapeutics

    NEW Drugs in Dev: 8
    Evonik

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    End-to-end drug development, specializing in high-potency softgels and liquids, providing global partners with a competitive advantage.

    Virtual Booth

    Contact Supplier

    Kewpie is your partner for Sodium Hyaluronate & Hyaluronic Acid// CEP, USDMF, KDMF & JDMF registered.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Atara Biotherapeutics (Nasdaq:ATRA) is a leading off-the-shelf, allogeneic T-cell immunotherapy company developing novel treatments for patients with cancer, autoimmune and viral diseases. The company was founded in 2012 and named after Atara Ciechanover who suffered from cancer before passing away.Originating from over a decade of groundbreaking clinical experience at Memorial Sloan Kettering and QIMR Berghofer, Atara’s off...
    Atara Biotherapeutics (Nasdaq:ATRA) is a leading off-the-shelf, allogeneic T-cell immunotherapy company developing novel treatments for patients with cancer, autoimmune and viral diseases. The company was founded in 2012 and named after Atara Ciechanover who suffered from cancer before passing away.Originating from over a decade of groundbreaking clinical experience at Memorial Sloan Kettering and QIMR Berghofer, Atara’s off-the-shelf, allogeneic T cells are bioengineered from donors with healthy immune function and allow for rapid delivery from inventory to patients without a requirement for pretreatment.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Atara BiotherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    611 Gateway Blvd, Suite 900 South San Francisco, CA 94080
    Telephone
    Telephone
    (650) 278-8930
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.atarabio.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/atarabio
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/atarabio?lang=en

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    FDA Rejects Atara’s blood Cancer Treatment
    FDA Rejects Atara’s blood Cancer Treatment

    13 Jan 2026

    // REUTERS

    https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-declines-approve-ataras-therapy-rare-blood-cancer-2026-01-12/#:~:text=Jan%2012%20(Reuters)%20%2D%20The,down%2056%25%20in%20early%20trading.

    REUTERS
    13 Jan 2026
    Share Share
    Pierre Fabre Pharma Responds to Fda's CRL for Tabelecleucel
    Pierre Fabre Pharma Responds to Fda's CRL for Tabelecleucel

    12 Jan 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/pierre-fabre-pharmaceuticals-statement-regarding-receipt-of-complete-response-letter-for-tabelecleucel-biologics-license-application-from-the-us-food-and-drug-administration-302658114.html

    PR NEWSWIRE
    12 Jan 2026
    Share Share
    Atara Bio Reports Q3 Financials & Operational Advancements
    Atara Bio Reports Q3 Financials & Operational Advancements

    12 Nov 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251112949094/en/Atara-Biotherapeutics-Announces-Third-Quarter-Financial-Results-and-Operational-Progress

    BUSINESSWIRE
    12 Nov 2025
    Share Share
    Atara Biotherapeutics Announces Changes to Its Board of Directors
    Atara Biotherapeutics Announces Changes to Its Board of Directors

    03 Sep 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250903414165/en/Atara-Biotherapeutics-Announces-Changes-to-Its-Board-of-Directors

    BUSINESSWIRE
    03 Sep 2025
    Share Share
    Atara Biotherapeutics Reveals Q2 Financial Results and Progress
    Atara Biotherapeutics Reveals Q2 Financial Results and Progress

    11 Aug 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250811258417/en/Atara-Biotherapeutics-Announces-Second-Quarter-Financial-Results-and-Operational-Progress

    BUSINESSWIRE
    11 Aug 2025
    Share Share
    Pierre Takes Over Tabelecleucel Drug Application from Atara Bio
    Pierre Takes Over Tabelecleucel Drug Application from Atara Bio

    15 Jul 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/pierre-fabre-pharmaceuticals-inc-announces-transfer-of-investigational-new-drug-application-for-tabelecleucel-from-atara-biotherapeutics-inc-302504743.html

    PR NEWSWIRE
    15 Jul 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search